ER visits tied to ambien on the rise

ER visits tied to ambien on the rise
Adverse reactions to popular sleep meds rose almost 220 percent between 2005 and 2010, study finds.

(HealthDay)—There has been a dramatic increase in the number of emergency-room visits related to sleep medications such as Ambien, according to a new U.S. study.

to —the in the sleep aids Ambien, Ambien CR, Edluar and Zolpimist—rose almost 220 percent between 2005 and 2010, researchers from the U.S. Substance Abuse and Administration (SAMHSA) found.

The study authors concluded that use of these drugs for the short-term treatment of insomnia should be carefully monitored. Zolpidem, which has been approved by the U.S. , has been used safely and effectively by millions of Americans, but adverse reactions to the medication have increased. Most of these cases involved people aged 45 and older, the researchers said.

"Although short-term sleeping medications can help patients, it is exceedingly important that they be carefully used and monitored," SAMHSA administrator Pamela Hyde said in an agency news release. "Physicians and patients need to be aware of the potential adverse reactions associated with any medication, and work closely together to prevent or quickly address any problems that may arise."

Possible adverse reactions from medications containing zolpidem include:

  • Daytime drowsiness
  • Dizziness
  • Agitation
  • Sleep-walking
  • Drowsiness while driving

After analyzing findings from a system that monitors drug-related illnesses and deaths, the researchers found that emergency-room cases involving medications such as Ambien increased sharply from about 6,000 in 2005 to more than 19,000 in 2010.

Women were more often affected than men. The findings revealed that during the study time frame, there was a 274 percent increase in the number of women who went to the emergency room due to a reaction involving zolpidem, compared to a 144 percent increase among men. In 2010 alone, women accounted for 68 percent of all trips to the emergency room for an adverse reaction related to zolpidem, the researchers said.

The study authors also noted that adverse reactions to these sleep aids could be worsened when the medication is taken with other substances, such as certain anti-anxiety drugs and narcotic pain relievers.

The SAMHSA report said that in 2010, half of all emergency-room visits related to zolpidem involved its interaction with other drugs. Moreover, 37 percent of all emergency visits resulted from the combination of these and drugs that depress the central nervous system.

In response to the increase in adverse reactions, in January 2013 the FDA required drug manufacturers to cut the recommended dose for women in half. The FDA also recommended that drug companies reduce the dosage for men.

More information: The U.S. National Institutes of Health has more about zolpidem.

Related Stories

FDA requires lower doses for sleep medications (Update)

date Jan 10, 2013

(HealthDay)—The U.S. Food and Drug Administration announced Thursday that it is asking manufacturers of sleep medications containing zolpidem—including Ambien—to lower the recommended doses and to provide ...

US approves drug for middle-of-the-night insomniacs

date Nov 23, 2011

The US Food and Drug Administration, for the first time, approved Wednesday medication specifically designed for those who wake up in the middle of the night and cannot fall back to sleep.

ER visits linked to ADHD meds up sharply

date Jan 25, 2013

(HealthDay)—U.S. emergency department visits involving attention-deficit/hyperactivity disorder (ADHD) drugs more than doubled from 2005 to 2010, with the largest hike occurring among adults, says a new ...

Inpatient sleeping drug quadrupled fall risk

date Nov 19, 2012

A drug commonly prescribed to help patients sleep in hospitals has been associated with an increased risk of falls, according to a study published in the Journal of Hospital Medicine.

Is a better sleeping pill on the way?

date Apr 03, 2013

(HealthDay)—A new class of sleep medications appears to help people fall asleep without causing grogginess the next day, researchers say.

Recommended for you

Solid, heat-resistant vaccine to ease immunisation processes

date Apr 30, 2015

EU researchers have set out to substitute liquid and freeze-dried vaccines for new, solid state candidates. If successful, the research will enable the large scale production of new virosome-based vaccines with increased ...

Screening for bacteriuria in pregnant women: Benefit unclear

date Apr 30, 2015

Due to a lack of suitable studies, no conclusions can be drawn on the patient-relevant benefit or harm of screening for asymptomatic bacteriuria (ASB) in pregnant women. The benefit of antibiotic treatment of ASB following ...

First generic Abilify approved

date Apr 30, 2015

(HealthDay)—The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.